148 related articles for article (PubMed ID: 30167091)
1. Advantages of systematic trunk SPECT/CT to planar bone scan (PBS) in more than 300 patients with breast or prostate cancer.
Fleury V; Ferrer L; Colombié M; Rusu D; Le Thiec M; Kraeber-Bodéré F; Campion L; Rousseau C
Oncotarget; 2018 Aug; 9(60):31744-31752. PubMed ID: 30167091
[TBL] [Abstract][Full Text] [Related]
2. A Prospective Study Comparing
Löfgren J; Mortensen J; Rasmussen SH; Madsen C; Loft A; Hansen AE; Oturai P; Jensen KE; Mørk ML; Reichkendler M; Højgaard L; Fischer BM
J Nucl Med; 2017 Nov; 58(11):1778-1785. PubMed ID: 28798033
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. Incremental diagnostic utility of systematic double-bed SPECT/CT for bone scintigraphy in initial staging of cancer patients.
Guezennec C; Keromnes N; Robin P; Abgral R; Bourhis D; Querellou S; de Laroche R; Le Duc-Pennec A; Salaün PY; Le Roux PY
Cancer Imaging; 2017 Jun; 17(1):16. PubMed ID: 28592305
[TBL] [Abstract][Full Text] [Related]
5. Whole-body SPECT/CT for bone scintigraphy: diagnostic value and effect on patient management in oncological patients.
Palmedo H; Marx C; Ebert A; Kreft B; Ko Y; Türler A; Vorreuther R; Göhring U; Schild HH; Gerhardt T; Pöge U; Ezziddin S; Biersack HJ; Ahmadzadehfar H
Eur J Nucl Med Mol Imaging; 2014 Jan; 41(1):59-67. PubMed ID: 23974666
[TBL] [Abstract][Full Text] [Related]
6. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
[TBL] [Abstract][Full Text] [Related]
7. The improved accuracy of planar bone scintigraphy by adding single photon emission computed tomography (SPECT-CT) to detect skeletal metastases from prostate cancer.
McLoughlin LC; O'Kelly F; O'Brien C; Sheikh M; Feeney J; Torreggiani W; Thornhill JA
Ir J Med Sci; 2016 Feb; 185(1):101-5. PubMed ID: 25394725
[TBL] [Abstract][Full Text] [Related]
8. Comparison of hybrid
Janssen JC; Meißner S; Woythal N; Prasad V; Brenner W; Diederichs G; Hamm B; Makowski MR
Eur Radiol; 2018 Feb; 28(2):610-619. PubMed ID: 28779400
[TBL] [Abstract][Full Text] [Related]
9. A Prospective Comparison of
Anttinen M; Ettala O; Malaspina S; Jambor I; Sandell M; Kajander S; Rinta-Kiikka I; Schildt J; Saukko E; Rautio P; Timonen KL; Matikainen T; Noponen T; Saunavaara J; Löyttyniemi E; Taimen P; Kemppainen J; Dean PB; Blanco Sequeiros R; Aronen HJ; Seppänen M; Boström PJ
Eur Urol Oncol; 2021 Aug; 4(4):635-644. PubMed ID: 32675047
[TBL] [Abstract][Full Text] [Related]
10. Head-to-head comparison of
Zhang Y; Lin Z; Li T; Wei Y; Yu M; Ye L; Cai Y; Yang S; Zhang Y; Shi Y; Chen W
Sci Rep; 2022 Sep; 12(1):15993. PubMed ID: 36163353
[TBL] [Abstract][Full Text] [Related]
11. Should SPECT-CT replace SPECT for the evaluation of equivocal bone scan lesions in patients with underlying malignancies?
Ndlovu X; George R; Ellmann A; Warwick J
Nucl Med Commun; 2010 Jul; 31(7):659-65. PubMed ID: 20395878
[TBL] [Abstract][Full Text] [Related]
12. Incremental Value of Single-photon Emission Computed Tomography-computed Tomography for Characterization of Skeletal Lesions in Breast Cancer Patients.
Mahaletchumy T; AbAziz A
World J Nucl Med; 2017; 16(4):303-310. PubMed ID: 29033679
[TBL] [Abstract][Full Text] [Related]
13. The added value of multislice SPECT/CT in patients with equivocal bony metastasis from carcinoma of the prostate.
Helyar V; Mohan HK; Barwick T; Livieratos L; Gnanasegaran G; Clarke SE; Fogelman I
Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):706-13. PubMed ID: 20016889
[TBL] [Abstract][Full Text] [Related]
14. F-18 fluoro-deoxy-glucose and F-18 sodium fluoride cocktail PET/CT scan in patients with breast cancer having equivocal bone SPECT/CT.
Harisankar CN; Agrawal K; Bhattacharya A; Mittal BR
Indian J Nucl Med; 2014 Apr; 29(2):81-6. PubMed ID: 24761058
[TBL] [Abstract][Full Text] [Related]
15. Bone scintigraphy in breast cancer: added value of hybrid SPECT-CT and its impact on patient management.
Sharma P; Singh H; Kumar R; Bal C; Thulkar S; Seenu V; Malhotra A
Nucl Med Commun; 2012 Feb; 33(2):139-47. PubMed ID: 22157698
[TBL] [Abstract][Full Text] [Related]
16. Comparison of bone scintigraphy and
Pyka T; Okamoto S; Dahlbender M; Tauber R; Retz M; Heck M; Tamaki N; Schwaiger M; Maurer T; Eiber M
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2114-2121. PubMed ID: 27290607
[TBL] [Abstract][Full Text] [Related]
17. Impact of additional SPECT in bone scanning in tumor patients with suspected metastatic bone disease.
Apostolova I; Gölcük E; Bohuslavizki KH; Buchert R; Brenner W
Ann Nucl Med; 2009 Dec; 23(10):869-75. PubMed ID: 19924378
[TBL] [Abstract][Full Text] [Related]
18. Added value of SPECT/CT in patients suspected of having bone infection: preliminary results.
Horger M; Eschmann SM; Pfannenberg C; Storek D; Vonthein R; Claussen CD; Bares R
Arch Orthop Trauma Surg; 2007 Apr; 127(3):211-21. PubMed ID: 17146681
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial.
Jambor I; Kuisma A; Ramadan S; Huovinen R; Sandell M; Kajander S; Kemppainen J; Kauppila E; Auren J; Merisaari H; Saunavaara J; Noponen T; Minn H; Aronen HJ; Seppänen M
Acta Oncol; 2016; 55(1):59-67. PubMed ID: 25833330
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of whole-body SPECT/CT in bone metastasis detection using
Alqahtani MM; Fulton R; Constable C; Willowson KP; Kench PL
Clin Radiol; 2020 Dec; 75(12):961.e11-961.e24. PubMed ID: 32868091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
